The thymic medulla is dedicated for purging the T-cell receptor (TCR) repertoire of self-reactive specificities. Medullary thymic epithelial cells (mTECs) play a pivotal role in this process because they express numerous peripheral tissue-restricted self-antigens. Although it is well known that medulla formation depends on the development of single-positive (SP) thymocytes, the mechanisms underlying this requirement are incompletely understood. We demonstrate here that conventional SP CD4⁺ thymocytes bearing autoreactive TCRs drive a homeostatic process that fine-tunes medullary plasticity in adult mice by governing the expansion and patterning of the medulla. This process exhibits strict dependence on TCR-reactivity with self-antigens expressed by mTECs, as well as engagement of the CD28-CD80/CD86 costimulatory axis. These interactions induce the expression of lymphotoxin α in autoreactive CD4⁺ thymocytes and RANK in mTECs. Lymphotoxin in turn drives mTEC development in synergy with RANKL and CD40L. Our results show that Ag-dependent interactions between autoreactive CD4⁺ thymocytes and mTECs fine-tune homeostasis of the medulla by completing the signaling axes implicated in mTEC expansion and medullary organization.
The thymic medulla is dedicated for purging the T-cell receptor (TCR) repertoire of self-reactive specificities. Medullary thymic epithelial cells (mTECs) play a pivotal role in this process because they express numerous peripheral tissue-restricted self-antigens. Although it is well known that medulla formation depends on the development of single-positive (SP) thymocytes, the mechanisms underlying this requirement are incompletely understood. We demonstrate here that conventional SPCD4⁺ thymocytes bearing autoreactive TCRs drive a homeostatic process that fine-tunes medullary plasticity in adult mice by governing the expansion and patterning of the medulla. This process exhibits strict dependence on TCR-reactivity with self-antigens expressed by mTECs, as well as engagement of the CD28-CD80/CD86 costimulatory axis. These interactions induce the expression of lymphotoxin α in autoreactive CD4⁺ thymocytes and RANK in mTECs. Lymphotoxin in turn drives mTEC development in synergy with RANKL and CD40L. Our results show that Ag-dependent interactions between autoreactive CD4⁺ thymocytes and mTECs fine-tune homeostasis of the medulla by completing the signaling axes implicated in mTEC expansion and medullary organization.
The thymus ensures the generation of a self-tolerant T cell receptor (TCR) repertoire. Tolerance to self-antigens (Ags) is established in the medulla, a specialized microenvironment mainly composed of medullary thymic epithelial cells (mTECs) and dendritic cells (DCs). mTECs are critical for inducing self-tolerance because they constitute a thymic reservoir of numerous peripheral tissue-restricted self-Ags (TRAs) 1,2. Defective TRA expression results in autoimmunity 3. mTECs can present TRAs to autoreactive CD8+ and CD4+ SP thymocytes to promote their deletion or the generation of natural regulatory T cells 4,5,6. TRAs expressed by mTECs are also captured by thymic DCs, which help to purge the thymocyte repertoire of autoreactive TCR specificities 4. Negative selection is further reinforced by circulating DCs displaying self-Ags captured in the periphery 7. The medulla thus ensures the establishment of T-cell tolerance via tight collaboration between mTECs and DCs 8.Mice presenting a block in thymocyte development at the double-positive (DP) stage exhibit small scattered medullary islets 9,10,11, indicating that medulla formation requires SP thymocytes 12. SP thymocytes and mTECs thus engage in a bidirectional “crosstalk” that controls formation and organization of the medulla 12,13 as well as thymocyte deletion. We recently discovered that autoreactive CD4+ thymocytes play a privileged role in governing the development of the mTEC subset that displays a fully mature phenotype, which constitutes approximately 20% of the total mTEC population 14. However, the nature of the cellular interactions and molecular mechanisms that controls development and architectural organization of the entire medullary compartment remains poorly understood.Three members of the tumor necrosis factor receptor superfamily and their ligands have been implicated in mTEC development 13,14,15,16,17,18. Cooperation between the engagement of receptor activator of nuclear factor Kappa B (RANK) and CD40 on mTECs by RANKL and CD40L expressed by SP thymocytes determines mature mTEC cellularity in adult mice 16 while lymphotoxin β receptor (LTβR) and LTα1β2 (LT) influence medulla organization 19,20,21. However, the respective roles of these three signaling axes in medulla development, and the sequence in which they operate, remain elusive.We demonstrate here that conventional autoreactive CD4+ thymocytes are essential and sufficient for fostering total mTEC expansion and determining the 3-dimensional (3D) organization of the entire medullary compartment. This critical function of autoreactive CD4+ thymocytes is mediated by Ag-dependent interactions with mTECs displaying cognate Ag-MHCII complexes and engagement of the CD28-CD80/86 costimulatory axis. This crosstalk induces LTα expression in the CD4+ thymocytes and RANK in mTECs, thereby completing two of the three signaling axes regulating medulla formation and organization. Finally, we show that the crosstalk between autoreactive CD4+ thymocytes and mTECs is a dynamic homeostatic process that governs the remarkable plasticity of the postnatal medulla, allowing it to adapt its size and organization to the output of autoreactive thymocytes.
Materials And Methods
Mice
Mice were on a C57BL/6 background, specific-pathogen-free and sacrificed at 5–8 weeks of age. β2m
−/−
22, H2-Aα
−/−
23, CIIta
IV-/IV-
24, TCRα
−/−
25, Rag2
−/−
26, Marilyn:Rag2
−/−
27, 3BBM74:Rag2
−/−
28, B3K508:Rag1
−/−
29, LTα−/−
30, CD80/86−/−
31, CD28−/−
32 and Foxp3DTR 33 mice have been described. RIP-mOVA 34 and OTII 35 mice were backcrossed onto a Rag2
−/− background. All animal procedures were performed in accordance with the Institutional Ethical Committee of Animal Care in Geneva and Cantonal Veterinary Office. The Institutional Ethical Committee of Animal Care in Geneva and Cantonal Veterinary Office specifically approved this study through the experimentation ID: 1005-3697-3.
Bone Marrow Chimeras
Irradiated (900 rad) WT male recipients were injected i.v. with 5×106 bone marrow cells from WT and/or Marilyn:Rag2−/− males.
Thymic Sections
Frozen sections cut at 20-µm of thickness were stained with rabbit-anti keratin 14 (Covance) and rat-anti keratin 8 (abcam) and detected using Cy3-conjugated anti-rabbit IgG (Invitrogen) and Alexa Fluor 488-conjugated anti-rat IgG (Invitrogen), respectively. Sections were counterstained with DAPI and mounted with Mowiol (Calbiochem). Medullary areas were measured using Metamorph. For 3D reconstructions, medullas were delimited based on K14 staining using Matlab. Medullary volumes were computed using Imaris. Hematoxylin-Eosin (HE) stained sections (5-µm) were prepared from fixed (4% formaldehyde) paraffin-embedded thymuses. Images were acquired with a LSM 510 confocal microscope or a Mirax Midi scanner (Zeiss).
Tec Isolation And Flow Cytometry
TECs were prepared as described 14. Hematopoietic cells were depleted with anti-CD45 magnetic beads (Miltenyi Biotec) by AutoMACS. TECs and thymocytes were analyzed by FACS using a FACScalibur or a LSRII (Becton Dickinson). Cells were incubated for 15 min at 4°C with Fc-block (anti-CD16/CD32, PharMingen) before staining with the following antibodies: anti-CD45 (30-F11), anti-EpCAM (G8.8), anti-Ly51 (6C3), anti-CD80 (16-10A1), anti-I-Ab (AF6-120.1) and anti-LTα (AF.B3); all purchased from Pharmingen except for anti-EpCAM that was purchased from eBioscience. For intracellular Aire (5H12, eBioscience) and Ki67 (B56, PharMingen) stainings, cells were fixed and stained with BD Cytofix/Cytoperm and Perm/Wash (Biosciences). Gating on mTECs was performed as described 14.
Thymic Organ Culture
Thymic lobes from E15.5 C57BL/6 embryos were treated with 1.35 mM 2′-deoxiguanosine (2-dGUO, Sigma) for 6 days. For FTOC, 2-dGUO-treated lobes were cultured for 4 days in DMEM supplemented with 2 µg/ml RANKL (R&D Systems), 5 µg/ml CD40L (R&D Systems) and/or 2 µg/ml agonistic anti-LTβR antibody (clone 4H8) 36. RTOCs were performed as described 37. 2-dGUO treated lobes were disaggregated to obtain thymic stroma. CD4+CD8+βTCRlo/intHSAhi thymocytes were sorted from 3 week old OTII:Rag2
−/− mice. Stromal cells and thymocytes were mixed in a 1∶3 ratio and cultured as standing drops. After 5 days, RTOCs were digested to single cell suspensions for flow cytometry analysis.
Rt-Pcr
Real-time RT-PCR was performed as described 14. GAPDH mRNA was used for normalization. Primer sequences are available upon request.
Thymocyte Purification And Activation
Thymocytes were incubated at 4°C with Fc-block, then with anti-CD4 (RM4-5, Pharmingen) and anti-CD8a antibodies (53-6.7, Pharmingen). DN, DP and SP thymocytes were sorted with a FACSVantage (Becton Dickinson). Cell purity was more than 90%. Thymocytes were stimulated for 24 h in RPMI with 1 µg/ml anti-CD28 antibodies (37.51, Pharmingen) in 96 well plates pre-coated with 2 µg/ml of anti-CD3 antibodies (145-2C11, Pharmingen), or by co-culture with OVAp-loaded mTECs.
Peptide Injection
4–9 week old mice were injected i.v. with 85 nmol of <span class="Chemical">OVAp (OVA323–339, ISQAVHAAHAEINEAGR) or H-Yp (NAGFNSNRANSSRSS).
Statistics
Statistical significance was assessed by two-tailed Student's t test: ***, p<0.001; **, p<0.01; *, p<0.05.
Results
Cd4+ Thymocytes Are Critical For Sustaining Medulla Formation
We had previously reported that CD4+ thymocytes development is critical for determining the cellularity of mature <span class="Gene">Aire+ mTECs 14. However, it was not known whether CD4+ thymocytes also play a privileged role in governing total mTEC cellularity and/or patterning of the medulla. To address this question, thymic sections from wild-type (WT), β2m
−/− (lacking CD8+ thymocytes), H2-Aα
−/− (lacking CD4+ thymocytes) and TCRα
−/− (lacking SP thymocytes) mice were stained with antibodies directed against the cortical TEC (cTEC) marker keratin 8 (K8) and the mTEC marker keratin 14 (K14) (Figure 1A). Medullary areas were larger in both β2m
−/− and H2-Aα
−/− mice compared to TCRα
−/− mice, which contain only rudimentary medullas 11,17,38. However, whereas medullary areas were of WT size in β2m
−/− mice, they were markedly underdeveloped in H2-Aα
−/− mice. We also quantified medullary areas by HE staining of thymic sections from WT, β2m
−/−, H2-Aα
−/− and CIIta
IV-/IV- mice (Figure 1B). Like H2-Aα
−/− thymi, CIIta
IV-/IV- thymi lack CD4+ thymocytes 39. Medullary size distributions were strongly skewed towards smaller sizes in H2-Aα
−/− and CIIta
IV-/IV- mice but similar to WT in β2m
−/− mice. Consistently, the medullary volume was also reduced in H2-Aα
−/− mice compared to WT and β2m
−/− mice (data not shown).
Figure 1
Medulla formation is defective in mice lacking CD4+ thymocytes.
(A) Sections from WT, β2m
−/−, H2-Aα
−/− and TCRα
−/− thymi were stained with antibodies against K14 and K8; m, medulla. The graph shows medullary areas obtained from 3 experiments: symbols represent individual confocal images; lines represent medians. (B) The distribution of medullary areas (mm2) counterstained with HE is shown for WT, β2m
−/−, H2-Aα
−/− and CIIta
IV-/IV- mice: 3 mice per genotype; number of sections is 87 for WT, 90 for β2m
−/−, 91 for H2-Aα
−/− and 78 for CIIta
IV-/IV-; significance relative to WT. (C) Representative FACS profiles are shown (top) for Ly51 expression by CD45−EpCAM+ TECs from WT, β2m
−/−, H2-Aα−/− and CIItaIV-/IV- mice: percentages of cells are indicated. Percentages (bottom left) and numbers per thymus (bottom right) of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs are shown: means and SD from 3 measurements; significance relative to WT.
Medulla formation is defective in mice lacking CD4+ thymocytes.
(A) Sections from WT, β2m
−/−, H2-Aα
−/− and TCRα
−/− thymi were stained with antibodies against <span class="Gene">K14 and K8; m, medulla. The graph shows medullary areas obtained from 3 experiments: symbols represent individual confocal images; lines represent medians. (B) The distribution of medullary areas (mm2) counterstained with HE is shown for WT, β2m
−/−, H2-Aα
−/− and CIIta
IV-/IV- mice: 3 mice per genotype; number of sections is 87 for WT, 90 for β2m
−/−, 91 for H2-Aα
−/− and 78 for CIIta
IV-/IV-; significance relative to WT. (C) Representative FACS profiles are shown (top) for Ly51 expression by CD45−EpCAM+ TECs from WT, β2m
−/−, H2-Aα−/− and CIItaIV-/IV- mice: percentages of cells are indicated. Percentages (bottom left) and numbers per thymus (bottom right) of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs are shown: means and SD from 3 measurements; significance relative to WT.
Significant reductions in total mTEC frequencies and matching increases in cTEC frequencies were evident in H2-Aα
−/− and CIIta
IV-/IV- mice (Figure 1C). In contrast, mTEC and cTEC frequencies were similar to WT in β2m
−/− mice. Absolute mTEC numbers were strongly reduced in H2-Aα
−/− and CIIta
IV-/IV- thymi, whereas cTEC numbers were unchanged (Figure 1C). Reductions in mTEC numbers in H2-Aα
−/− and CIIta
IV-/IV- mice affected both mature (Aire+, CD80hi) and immature (CD80int) mTEC subsets (Figure S1A).Defective medulla formation in the absence of CD4+ thymocytes was not associated with altered DC populations. Frequencies and numbers of plasmacytoid DCs (CD11cintPDCA1+), migrating cDCs (CD11chiCD8α
loSirpαhi) and intrathymic cDCs (CD11chiCD8α
hiSirpαlo) were similar in WT, β2m
−/−, H2-Aa
−/− and CIIta
IV-/IV- mice (Figure S1B). No difference in medullary localization of DCs was observed (Figure S1C).These results demonstrate that CD4+ thymocytes are required and sufficient for sustaining medulla formation by controlling total mTEC cellularity. This selective dependence on CD4+ thymocytes is specific of mTECs, as a block in CD4+ thymocyte development has no adverse effects on DCs.
Ag-Specific Interactions With Cd4+ Thymocytes Control Medulla Formation And Organization
We previously reported that the development mature Aire+ mTECs is fostered by Ag-specific interactions with CD4+ thymocytes 14. TCRtransgenic mice were therefore used to determine whether CD4+ thymocyte driven medulla formation and organization also require Ag-specificity. We first compared medullas between male and female Marilyn:Rag2
−/− mice, which carry an MHCII-restricted TCR recognizing the male-specific H-Y Ag 27. In these mice, CD4+ thymocytes are deleted in males but not in females 14. Thymic sections from Rag2
−/− mice and Marilyn:Rag2
−/− females or males were stained for K8 and K14 (Figure 2A). Medullary areas were enlarged only modestly in Marilyn:Rag2
−/− females compared to Rag2
−/− mice, but increased dramatically in Marilyn:Rag2
−/− males. This strong medullary expansion was accompanied by a marked increase in mTEC numbers (Figure 2B).
Figure 2
Medulla formation is controlled by autoreactive CD4+ thymocytes.
(A) Thymic sections from Rag2
−/− mice and Marilyn:Rag2
−/− females or males were stained with antibodies against K8 and K14: m, medulla. The graph shows quantifications of medullary areas: symbols represent individual confocal images; lines represent medians; data from 3 experiments, each with 2–3 mice per group. (B) The graph shows numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs in Marilyn:Rag2
−/− females and males: means and SD from 3 experiments. (C) Representative FACS profiles are shown for Ly51 expression by CD45−EpCAM+ TECs from WT→WT and mixed H-Y+WT→WT (1∶1 ratio) chimeras. Graphs show percentages of CD45−EpCAM+Ly51−/lo mTECs and numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs for chimeras prepared with the indicated H-Y∶WT BM ratio: means and SD derived from 3 measurements; significance relative to WT→WT chimeras (0∶1 ratio). (D) Representative FACS profiles are shown for Ki67 expression by CD45−EpCAM+Ly51−/lo mTECs from WT→WT and mixed H-Y+WT→WT (1∶1 ratio) chimeras. Graphs show percentages and numbers per thymus of Ki67+ mTECs for chimeras prepared with the indicated H-Y∶WT BM ratio: means and SD from 3 measurements; significance relative to WT→WT chimeras (0∶1 ratio).
Medulla formation is controlled by autoreactive CD4+ thymocytes.
(A) Thymic sections from Rag2
−/− <span class="Species">mice and Marilyn:Rag2
−/− females or males were stained with antibodies against K8 and K14: m, medulla. The graph shows quantifications of medullary areas: symbols represent individual confocal images; lines represent medians; data from 3 experiments, each with 2–3 mice per group. (B) The graph shows numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs in Marilyn:Rag2
−/− females and males: means and SD from 3 experiments. (C) Representative FACS profiles are shown for Ly51 expression by CD45−EpCAM+ TECs from WT→WT and mixed H-Y+WT→WT (1∶1 ratio) chimeras. Graphs show percentages of CD45−EpCAM+Ly51−/lo mTECs and numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs for chimeras prepared with the indicated H-Y∶WT BM ratio: means and SD derived from 3 measurements; significance relative to WT→WT chimeras (0∶1 ratio). (D) Representative FACS profiles are shown for Ki67 expression by CD45−EpCAM+Ly51−/lo mTECs from WT→WT and mixed H-Y+WT→WT (1∶1 ratio) chimeras. Graphs show percentages and numbers per thymus of Ki67+ mTECs for chimeras prepared with the indicated H-Y∶WT BM ratio: means and SD from 3 measurements; significance relative to WT→WT chimeras (0∶1 ratio).
The role of autoreactive CD4+ thymocytes in driving mTEC cellularity was further assessed by generating mixed BM chimeras in which irradiated WT males were reconstituted with variable mixtures of BM from WT and Marilyn:Rag2
−/− males (Figure 2C). Reconstitution with Marilyn:Rag2
−/− BM increased mTEC cellularity to greater than WT levels in a dose dependent manner. This was associated with a significant increase in proliferating Ki67+ mTECs (Figure 2D), suggesting that autoreactive CD4+ thymocytes amplify mTEC cellularity directly by stimulating their proliferation.We next studied medulla formation in OTII:Rag2
−/− mice, which express an MHCII-restricted TCR specific for ovalbumin (OVA), and OTII:Rag2
−/− mice carrying a RIP-mOVA transgene driving the synthesis of membrane-bound OVA in mTECs 40. Medullary areas were increased only slightly in OTII:Rag2
−/− mice relative to Rag2
−/− controls. They were however expanded markedly in RIP-mOVA:OTII:Rag2
−/− mice (Figure 3A). This was accompanied by a strong increase in total mTEC numbers (Figure 3B). CD4+ thymocytes in both OTII:Rag2
−/− and RIP-mOVA:OTII:Rag2
−/− mice upregulated expression of the chemokine receptor CCR7, enabling their migration into the medulla, where its ligand CCL21 is produced (data not shown). Positive selection also induced similar upregulation in TCR and CD3 expression in the two strains of mice (data not shown). Differential medulla expansion in OTII:Rag2
−/− and RIP-mOVA:OTII:Rag2
−/− mice could thus not be explained by differences in migration of CD4+ thymocytes into the medulla or in TCR upregulation upon positive selection.
Figure 3
mTEC cellularity is controlled by Ag-specific interactions with CD4+ thymocytes.
(A) Sections from Rag2
−/−, OTII:Rag2
−/− and Rip-mOVA:OTII:Rag2
−/− thymi were stained with antibodies against K8 and K14: m, medulla. The graph shows quantifications of medullary areas: symbols represent individual confocal images; lines represent medians; data from 3 experiments, each with 2–3 mice per group. (B) The graph shows numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs: means and SD from 3 measurements; significance relative to WT. (C) RTOCs using OTII:Rag2
−/− DP thymocytes were cultured for 5 days with (+) or without (−) OVAp. Control cultures contained no thymocytes (none) or WT DP thymocytes (DP-B6). Representative FACS profiles are shown for Ly51 expression by CD45−EpCAM+ TECs: percentages of cells are indicated. Graphs show frequencies of EpCAM+Ly51+ cTECs and EpCAM+Ly51−/lo mTECs (left) or numbers of EpCAM+Ly51−/lo mTECs (right). (D) Representative FACS profiles are shown for the expression of I-Ab and CD80 by mTECs in RTOCs cultured with (+) or without (−) OVAp: percentage of cells are indicated. Graphs show frequencies and numbers of mature I-AbhiCD80hi mTECs: data from 4 experiments, each with 3–5 RTOCs per condition.
mTEC cellularity is controlled by Ag-specific interactions with CD4+ thymocytes.
(A) Sections from Rag2
−/−, OTII:<span class="Gene">Rag2
−/− and Rip-mOVA:OTII:Rag2
−/− thymi were stained with antibodies against K8 and K14: m, medulla. The graph shows quantifications of medullary areas: symbols represent individual confocal images; lines represent medians; data from 3 experiments, each with 2–3 mice per group. (B) The graph shows numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs and CD45−EpCAM+Ly51+ cTECs: means and SD from 3 measurements; significance relative to WT. (C) RTOCs using OTII:Rag2
−/− DP thymocytes were cultured for 5 days with (+) or without (−) OVAp. Control cultures contained no thymocytes (none) or WT DP thymocytes (DP-B6). Representative FACS profiles are shown for Ly51 expression by CD45−EpCAM+ TECs: percentages of cells are indicated. Graphs show frequencies of EpCAM+Ly51+ cTECs and EpCAM+Ly51−/lo mTECs (left) or numbers of EpCAM+Ly51−/lo mTECs (right). (D) Representative FACS profiles are shown for the expression of I-Ab and CD80 by mTECs in RTOCs cultured with (+) or without (−) OVAp: percentage of cells are indicated. Graphs show frequencies and numbers of mature I-AbhiCD80hi mTECs: data from 4 experiments, each with 3–5 RTOCs per condition.
Analysis of two other strains of TCR-transgenic mice, namely BBM74:Rag2
−/−
28 and B3K508:Rag1
−/−
29 mice, confirmed that positively-selected CD4+ thymocytes are not sufficient for inducing medulla expansion in the absence of cognate Ag. In both strains, medullas were as underdeveloped as in OTII:Rag2
−/− mice (Figure S2A). Furthermore, leaky development of CD4+ thymocytes bearing non-transgenicTCRs in OTII:Rag2+/+ mice (∼1.7% of total CD4+ thymocytes, ∼3.5±0.4×105 cells) was sufficient to drive WT medulla formation and mTEC development (Figure S2B–C). Low numbers of polyclonal CD4+ thymocytes comprising autoreactive specificities thus suffice to sustain medulla formation.We previously established that the development of mature Aire+ mTECs could be driven by WT CD4+ thymocytes in reaggregated thymic organ culture (RTOC) experiments 14. We therefore used RTOC to determine whether Ag-specific interactions with CD4+ thymocytes were required for promoting mTEC development in vitro. 2-dGUO-treated fetal thymic stroma was reaggregated with OTII:Rag2
−/− thymocytes in the presence or absence of OVA peptide (OVAp) (Figure 3C–D). mTEC development remained at baseline levels in RTOCs performed with OTII thymocytes in the absence of OVAp. In contrast, the addition of OVAp induced strong increases in the frequencies and numbers of total and mature mTECs, reaching levels equivalent to those induced by WT thymocytes.To determine whether medullary defects in TCR-transgenic mice can be corrected in vivo by providing the cognate Ag, we injected OVAp into adult OTII:Rag2
−/− mice. After 5–7 days, medullary areas were strongly enlarged compared to PBS-injected controls (Figure 4A and S3A). This was accompanied by marked increases in total mTEC numbers (Figure 4B) and frequencies of proliferating Ki67+ mTECs (Figure 4C). OVAp injection also induced strong increases in mature mTECs, with enhanced Aire and Aire-dependent TRA expression (Figure S3B). 3D reconstructions of thymic lobes confirmed that medullary volume was increased in the OVAp-injected mice (1.4%) compared to PBS-injected controls (0.7%) (Figure S4A, movies S1, S2). In the OVAp-injected mice, individual medullary islets were reduced in number and had a larger size distribution (Figure S4B). OVAp injection thus led to marked remodeling of the 3D organization of the medulla. Similar results were obtained by injecting the H-Y Dby peptide (H-Yp) into Marilyn:Rag2
−/− females (Figure 4D, Figure S4C–D, movies S3, S4).
Figure 4
Ag-injection restores medulla formation in TCR transgenic mice.
(A) Thymic sections from OTII:Rag2
−/− mice injected with PBS or OVAp were stained with antibodies against K14: m, medulla; c, cortex. The graph shows medullary areas: data from 3 experiments, each with 3 mice per group; symbols represent individual confocal images; lines represent medians. (B) The graph shows numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs in OTII:Rag2
−/− mice injected with PBS or OVAp. (C) The graph shows percentages of Ki67+ mTECs in OTII:Rag2
−/− mice injected with PBS or OVAp: means and SD from 3 experiments, each with 3 mice per genotype. (D) Thymic sections from Marilyn:Rag2
−/− females injected with PBS or H-Yp were stained with antibodies against K14: m, medulla; c, cortex. The graph shows medullary areas: data from 3 experiments, each with 3 mice per group; symbols represent individual confocal images; lines represent medians.
Ag-injection restores medulla formation in TCR transgenic mice.
(A) Thymic sections from OTII:Rag2
−/− <span class="Species">mice injected with PBS or OVAp were stained with antibodies against K14: m, medulla; c, cortex. The graph shows medullary areas: data from 3 experiments, each with 3 mice per group; symbols represent individual confocal images; lines represent medians. (B) The graph shows numbers per thymus of CD45−EpCAM+Ly51−/lo mTECs in OTII:Rag2
−/− mice injected with PBS or OVAp. (C) The graph shows percentages of Ki67+ mTECs in OTII:Rag2
−/− mice injected with PBS or OVAp: means and SD from 3 experiments, each with 3 mice per genotype. (D) Thymic sections from Marilyn:Rag2
−/− females injected with PBS or H-Yp were stained with antibodies against K14: m, medulla; c, cortex. The graph shows medullary areas: data from 3 experiments, each with 3 mice per group; symbols represent individual confocal images; lines represent medians.
Taken together, these results establish that autoreactive CD4+ thymocytes control development and organization of the thymic medulla in an Ag-dependent manner. This dynamic homeostatic process operates in adult mice and controls mTEC proliferation, medullary growth and 3D patterning of the medulla.
Ltβr-Signaling Controls Mtec Cellularity In Synergy With Rank And Cd40
Although it has been established that RANKL-RANK, CD40L-CD40 and LT-LTβR signaling contribute to mTEC development [14],[15],[16],[17],[19], the respective role of these three signaling axes remain unclear. To investigate this question, 2-dGUO-treated thymic lobes were cultured with agonistic anti-LTβR antibodies, CD40L and/or RANKL (Figure 5). Anti-LTβR antibodies induced a significant increase in total mTEC numbers. Little increase was induced by RANKL and CD40L, alone or in combination. Synergistic increases in mTEC numbers were observed when anti-LTβR antibodies were combined with RANKL, CD40L or both. Combining all 3 stimuli induced total mTEC numbers equivalent to those induced by thymocytes. A different division of labor emerged when mature mTECs were quantified (Figure 5A–B). RANKL and CD40L each induced a modest increase in the proportion of mature mTECs. A synergistic increase was obtained when RANKL and CD40L were added together, attaining control levels induced by thymocytes. In contrast, anti-LTβR antibodies had little or no influence on mature mTEC frequencies, either when added alone or in combination with RANKL, CD40L or both. Signaling via LTβR, CD40 and RANK thus make distinct contributions to mTEC cellularity and maturation. LTβR-signaling has a dominant role in determining total mTEC cellularity. Conversely, CD40 and RANK are critical for driving the development of mature mTEC.
Figure 5
Roles of LTβR, RANK and CD40 signaling in mTEC expansion and maturation.
2-dGUO-treated WT embryonic thymic lobes were cultured for 4 days in medium containing agonistic anti-LTβR antibodies, CD40L and/or RANKL. Control cultures were un-supplemented (medium) or not treated with 2-dGUO. (A) Representative FACS profiles are shown for Ly51 expression by CD45−EpCAM+ TECs (top) and I-Ab and CD80 expression by CD45−EpCAM+Ly51−/lo mTECs (bottom) for the indicated cultures: percentages of cells are indicated. (B) Graphs show mTEC numbers (left) and frequencies of mature I-AbhiCD80hi mTECs (right) for the indicated conditions: data from 3 experiments; lines represent medians.
Roles of LTβR, RANK and CD40 signaling in mTEC expansion and maturation.
2-dGUO-treated WT embryonic thymic lobes were cultured for 4 days in medium containing agonistic anti-LTβR antibodies, CD40L and/or RANKL. Control cultures were un-supplemented (medium) or not treated with 2-dGUO. (A) Representative FACS profiles are shown for Ly51 expression by CD45−EpCAM+ TECs (top) and I-Ab and CD80 expression by CD45−EpCAM+Ly51−/lo mTECs (bottom) for the indicated cultures: percentages of cells are indicated. (B) Graphs show mTEC numbers (left) and frequencies of mature I-AbhiCD80hi mTECs (right) for the indicated conditions: data from 3 experiments; lines represent medians.
Lt Expression Is Regulated In Cd4+ Thymocytes By Ag-Specific Interactions With Mtecs
To determine whether Ag-specific interactions with autoreactive CD4+ thymocytes might play a dominant role in inducing signals governing mTEC development, RANKL, CD40L, LTα and LTβ mRNAs were quantified by qRT-PCR in DP and CD4+ thymocytes from OTII:Rag2
−/− and Rip-mOVA:OTII:Rag2
−/− mice. In both strains, RANKL and CD40L mRNAs were upregulated strongly in CD4+ thymocytes relative to DP thymocytes. LTβ mRNA was also upregulated, albeit only ∼2-fold, in CD4+ thymocytes from both strains (Figure 6A). RANKL, CD40L and LTβ mRNAs were thus induced in positively-selected OTII thymocytes independently of OVA expression. In contrast, LTα mRNA expression was upregulated only in CD4+ thymocytes of Rip-mOVA:OTII:Rag2mice, suggesting that its induction occurs upon Ag-specific interactions with mTECs.
Figure 6
LT expression is induced by Ag-specific activation of CD4+ thymocytes.
(A) RANKL, CD40L, LTα and LTβ mRNAs were quantified in DP and CD4+ thymocytes from OTII:Rag2
−/− and Rip-mOVA:OTII:Rag2
−/− mice: means and SEM are from 3 experiments, each with 2 mice per group. (B) LTα mRNA and cell surface LT were assessed for unstimulated and anti-CD3/CD28-activated CD4+ thymocytes from OTII:Rag2
−/− or Marilyn:Rag2
−/− mice: data representative of 3 experiments. (C) LTα mRNA was quantified in CD4+ thymocytes from OTII:Rag2
−/− mice co-cultured with unloaded (none) or OVAp-loaded mTECs: data representative of 2 experiments. (D) LTα mRNA was quantified in CD4+ thymocytes from OTII:Rag2
−/− mice isolated 1.5 days after injection of PBS or OVAp: data representative of 3 experiments. (E) β-casein, CRP and RANK mRNAs were quantified in mTECs from WT, LTα−/− mice and OTII:Rag2
−/− mice 5 days after injection of PBS or OVAp. (F) LTα mRNA was quantified in DP and CD4+ thymocytes from CD80/86−/− mice: means and SEM are derived from 2 experiments, each with 2 mice per group. (G) Graphs show distributions of medullary areas (mm2) in WT, CD80/86−/− and CD28−/− thymi (left), and thymi from DT-treated WT and Foxp3-DTR mice (right): significance relative to WT. (H) Positive selection induces CD40L and RANKL expression in thymocytes. After migrating into the medulla, CD4+ thymocytes scan the surface of mTECs for the presence of auto-Ag–MHCII complexes. Ag-specific and CD28-CD80/86 dependent interactions between CD4+ thymocytes and mTECs induce the expression of LT in CD4+ thymocytes and RANK in mTECs, thereby completing the signaling axes required for promoting mTEC expansion and maturation.
LT expression is induced by Ag-specific activation of CD4+ thymocytes.
(A) RANKL, CD40L, LTα and LTβ mRNAs were quantified in DP and CD4+ thymocytes from OTII:Rag2
−/− and Rip-mOVA:OTII:Rag2
−/− mice: means and SEM are from 3 experiments, each with 2 mice per group. (B) LTα mRNA and cell surface LT were assessed for unstimulated and anti-CD3/CD28-activated CD4+ thymocytes from OTII:Rag2
−/− or Marilyn:Rag2
−/− mice: data representative of 3 experiments. (C) LTα mRNA was quantified in CD4+ thymocytes from OTII:Rag2
−/− mice co-cultured with unloaded (none) or OVAp-loaded mTECs: data representative of 2 experiments. (D) LTα mRNA was quantified in CD4+ thymocytes from OTII:Rag2
−/− mice isolated 1.5 days after injection of PBS or OVAp: data representative of 3 experiments. (E) β-casein, CRP and RANK mRNAs were quantified in mTECs from WT, LTα−/− mice and OTII:Rag2
−/− mice 5 days after injection of PBS or OVAp. (F) LTα mRNA was quantified in DP and CD4+ thymocytes from CD80/86−/− mice: means and SEM are derived from 2 experiments, each with 2 mice per group. (G) Graphs show distributions of medullary areas (mm2) in WT, CD80/86−/− and CD28−/− thymi (left), and thymi from DT-treated WT and Foxp3-DTR mice (right): significance relative to WT. (H) Positive selection induces CD40L and RANKL expression in thymocytes. After migrating into the medulla, CD4+ thymocytes scan the surface of mTECs for the presence of auto-Ag–MHCII complexes. Ag-specific and CD28-CD80/86 dependent interactions between CD4+ thymocytes and mTECs induce the expression of LT in CD4+ thymocytes and RANK in mTECs, thereby completing the signaling axes required for promoting mTEC expansion and maturation.Three approaches confirmed that LT expression is induced in CD4+ thymocytes by TCR engagement. First, LTα mRNA and cell-surface LT expression were upregulated by activating CD4+ thymocytes from OTII:Rag2
−/− mice or Marilyn:Rag2
−/− females with anti-CD3/CD28 antibodies (Figure 6B). Second, LTα mRNA was upregulated selectively in OTII:Rag2
−/− thymocytes co-cultured with OVAp-loaded mTECs (Figure 6C). Finally, injection of OTII:Rag2
−/− mice with OVAp induced LTα mRNA expression in CD4+ thymocytes in vivo (Figure 6D). This Ag-induced LT expression had functional consequences at the level of mTECs, since LT-dependent TRA and RANK expression were strongly induced in mTECs of OVAp-injected mice (Figure 6E). TRA and RANK expression was impaired to the same extent in mTECs from PBS-injected OTII:Rag2
−/− and LTα−/− mice, suggesting that autoreactive CD4+ thymocytes constitute the major source of LT.To confirm the role of physical interactions between CD4+ thymocytes and mTECs in controlling LT expression and medulla formation, we analyzed involvement of the CD28-CD80/86 costimulatory pathway. Upregulation of LTα mRNA was significantly impaired in CD4+ thymocytes of CD80/86−/− mice (Figure 6F). The size distribution of medullary areas was skewed towards smaller sizes in CD80/86−/− and CD28−/− mice (Figure 6G), as previously described for LTα−/− mice 20,21. Impaired medulla formation in CD80/86−/− and CD28−/− mice does not seem to result from abrogated natural regulatory T cell development 41,42, since no major reduction in medullary size was induced by regulatory T cell ablation in diphtheria-toxin treated Foxp3-DTR mice (Figure 6G). This suggests that conventional autoreactive CD4+ thymocytes, rather than natural regulatory T cells, are the major actors in regulating medulla formation.
Discussion
We investigated the respective contributions of CD4+ and CD8+ thymocytes to formation and patterning of the thymic medulla. Mice lacking CD8+ thymocytes exhibited normally sized medullary islets and WT mTEC numbers. In contrast, mice lacking CD4+ thymocytes exhibited poorly developed medullary islets and strongly reduced mTEC cellularity. CD4+ thymocytes are thus essential and sufficient for driving proper medulla growth, whereas CD8+ thymocytes are dispensable for sustaining this process. Despite this privileged role of CD4+ thymocytes, medulla formation was severely impaired in MHCII-restricted TCR-transgenic mice in which positive selection of CD4+ thymocytes occurs normally while there is no negative selection since the cognate Ag is absent. RTOC experiments also demonstrated that OTII thymocytes were unable to drive mTEC development in the absence of OVAp. Positively-selected CD4+ thymocytes are thus not sufficient per se for sustaining medulla formation. Instead, several lines of evidence indicate that medullary growth requires Ag-specific interactions between autoreactive CD4+ thymocytes and mTECs, similar to those that induce negative selection. First, OTII thymocytes can promote mTEC development in RTOCs as efficiently as WT thymocytes when OVAp is provided. Second, whereas mTEC cellularity was strongly decreased in OTII:Rag2
−/− mice and Marilyn:Rag2
−/− females, this defect was corrected in RIP-mOVA:OTII:Rag2
−/− mice and Marilyn:Rag2
−/− males, which express the cognate Ags. Third, medullary defects in OTII:Rag2−/− mice and Marilyn:Rag2−/− females could be corrected by injecting OVAp and H-Yp, respectively. The latter finding shows that defective medulla formation in these mice is not simply due to an intrinsic developmental block. It also emphasizes the remarkable plasticity of the medulla and indicates that the control of its size by autoreactive CD4+ thymocytes is a dynamic homeostatic process operating in adult mice. This is consistent with studies indicating that medullary defects in adult SCIDmice can be corrected by injecting mature T cells 43,44. Fourth, rare CD4+ thymocytes with non-transgenicTCR specificities in OTII:Rag
+/+ mice suffice to sustain medulla formation, suggesting that this process is sensitive to low numbers of autoreactive CD4+ thymocytes. This is consistent with the fact that SP thymocytes reside in the medulla for 4–5 days and are highly mobile, favoring numerous encounters with mTECs 45,46.We exploited OTII:Rag2
−/− and <span class="Gene">RIP-mOVA:OTII:Rag2
−/− mice to determine whether upregulation of LT, RANKL and CD40L expression in SPCD4+ thymocytes might be driven by Ag-specific interactions with mTECs. LTβ, RANKL and CD40L mRNAs were upregulated independently of OVA expression in both OTII:Rag2
−/− and RIP-mOVA:OTII:Rag2
−/− CD4+ thymocytes. Conversely, increased LTα mRNA expression was dependent on OVA expression by mTECs, as it was only observed in RIP-mOVA:OTII:Rag2
−/− mice. Upregulation of LT expression by TCR stimulation was confirmed in vitro by activating OTII thymocytes with anti-CD3/CD28 antibodies or by co-culture with OVAp-loaded mTECs. These results suggest that expression of RANKL and CD40L is induced by positive selection in the cortex whereas that of LT is activated by subsequent Ag-specific interactions with mTECs (Figure 6H). Activation of LT expression is thus uncoupled physically and temporally from the induction of RANKL and CD40L expression.
Cooperation between RANKL and CD40L signaling has been shown to be critical for mTEC development in the postnatal thymus 16,17. However, RANKL and CD40L expression by CD4+ thymocytes is not sufficient because mTEC development is severely impaired in OTII:Rag2−/− mice even though their thymocytes express both ligands. This could be reconciled by three non-mutually-exclusive mechanisms. First, efficient delivery of RANKL and CD40L signals to mTECs may require stable Ag-driven contacts with CD4+ thymocytes. Second, effective control of mTEC development by RANKL and CD40L requires collaboration with LT expression, which is induced in CD4+ thymocytes by Ag-dependent interactions with mTECs. Finally, LT produced by autoreactive CD4+ thymocytes enhances the responsiveness of mTECs to RANKL signals by inducing RANK expression in mTECs (Figure 6H).Our FTOC experiments indicated that LT, RANKL and CD40L signals make differential contributions to mTEC expansion and maturation. LTβR signaling was critical for fostering an increase in mTEC cellularity but had little effect on mTEC maturation. A key role of LTβR signaling in mTEC expansion is consistent with the observation that LTβR−/− and LTα−/− mice have small medullas 19,20,21 whereas LT over-expression in T cells leads to drastic medulla enlargement 47. In contrast to LTβR signaling, synergy between RANKL and CD40L was essential for driving mTEC maturation rather than increasing mTEC numbers. This is consistent with studies showing that mTEC maturation requires cooperation between RANKL and CD40L and that mTEC cellularity is decreased only modestly in RANKL−/− and CD40−/− mice 16,17.In conclusion, at least four parameters - medullary size, mTEC numbers, 3D organization of the medulla and mTEC maturation - are modulated in adult mice by Ag-specific and costimulatory-molecule-dependent interactions between autoreactive CD4+ thymocytes and mTECs displaying auto-Ag-MHCII complexes (Fig. 6H). These interactions induce LT expression by autoreactive CD4+ thymocytes and RANK expression by mTECs, thereby completing key signaling axes required for medulla formation (Fig. 6H). This unique crosstalk between autoreactive CD4+ thymocytes and mTECs regulates a homeostatic fine-tuning process that controls mTEC cellularity and 3D organization of the postnatal medulla, thereby maintaining a medullary microenvironment that is optimal for ensuring central T-cell tolerance.
mTECs but not DCs are impaired in mice lacking CD4 (A) Representative FACS profiles for the expression of Aire and CD80 by CD45−EpCAM+Ly51−/lo mTECs from WT, β2m
−/−, H2-Aα
−/− and CIIta
IV-/IV- mice: numbers represent the percentages of cells within the indicated gates. Graphs show number of Aire+, CD80hi, CD80int and CD80lo mTECs: the means and SD were derived from three measurements, each with three mice per genotype; statistical significance relative to WT. (B) Representative FACS profiles for the expression of CD11c and PDCA1 by CD45+ hematopoietic cells (top profiles), and the expression of Sirpα and CD8α by CD45+CD11chi cDCs (bottom profiles), are shown for thymi from WT, β2m
−/−, H2-Aα
−/− and CIIta
IV-/IV- mice. Graphs show numbers per thymus of CD11cintPDCA1+ pDCs, CD11chiCD8αloSirpα+ cDCs and CD11chiCD8αhiSirpα− cDCs for the indicated genotypes: the means and SEM are derived from two experiments, each with four to seven mice per group. Numbers of mice is indicated. (C) Thymic sections from WT, β2m
−/−, H2-Aα
−/− and CIIta
IV-/IV- mice were stained for the CD11c marker: m denotes the medulla. Results are representative of two experiments, each with two mice per group.
(TIFF)Click here for additional data file.
Positively-selected CD4
(A) Thymic sections from 3BBM74:Rag2
−/−, B3K508:Rag1
−/−, OTII:Rag2
−/− and WT mice were stained with antibodies against K8 and K14: m denotes the medulla; c denotes the cortex. Graphs show quantifications of the K14+ areas (left graph) and medullary areas (right graph) for each genotype: symbols represent individual confocal images; horizontal lines represent medians; data is pooled from three independent experiments, each with two to three mice per group. (B) Graphs show quantifications of the medullary areas, K14+ and MTS10+ areas in thymic sections from OTII:Rag2
−/−, OTII:Rag2
+/+ and WT mice: symbols represent individual confocal images; horizontal lines represent medians; data was pooled from three independent experiments, each with three mice per group. (C) Representative FACS profiles are shown for the expression of Ly51 by CD45−EpCAM+Ly51−/lo mTECs from OTII:Rag2
−/−, OTII:Rag2
+/+ and WT mice: numbers indicate percentages of cells within the indicated gates. Graphs show the percentages of mTECs and cTECs in the TEC population: the means and SD derived of three experiments are shown; statistical significance relative to WT.
(TIFF)Click here for additional data file.
Restoration of thymic medulla formation in
injection of the cognate Ag. (A) Thymic sections from OTII:Rag2
−/− mice injected with PBS or OVA323–339 were stained with antibodies against MTS10: m and c denote the medulla and cortex. The graph shows quantifications of MTS10+ medullary areas: data is pooled from three independent experiments, each with three mice per group; symbols represent individual confocal images; horizontal lines represent the medians. (B) Representative FACS profiles for the expression of Aire and CD80 by CD45−EpCAM+Ly51−/lo mTECs from OTII:Rag2
−/− mice injected with PBS or OVA323–339: numbers indicate the percentage of cells within the indicated gates. Graphs show the frequencies and numbers of Aire+ and CD80hi mTECs (means and SD derived from three experiments): number of mice is indicated. Aire and insulin mRNA expression were measured in mTECs pooled from 7 mice per group. (C) Thymic sections from Marilyn:Rag2
−/− mice injected i.v with PBS or H-Y Dby peptide were stained with antibodies against MTS10: m and c denote the medulla and cortex. The graph shows MTS10+ medullary areas: data is pooled from three independent experiments, each with three mice per group; symbols represent individual confocal images; horizontal lines represent the medians.
(TIFF)Click here for additional data file.
Injection of the cognate peptide induces expansion of the thymic medulla in
:
(A) OTII:Rag2
−/− mice were injected i.v with PBS or OVA323–339. 5 days later, 3D reconstructions of thymic lobes were generated from serial sections stained with antibodies against K14 and DAPI. 3D reconstructions depicting the thymic lobes (light blue, DAPI) and medulla (red, K14) are shown: axes are in mm. Volumes and percentages of the thymic medulla are indicated. (B) The graph depicts the volumes (mm3) of individual medullary islets in thymic lobes from OTII:Rag2
−/− mice injected with PBS or OVA323–339. Horizontal lines represent medians and SEM. Numbers of isolated medullary islets in the thymic lobes are indicated below. The 3D reconstructions can be visualized in movies S1, S2. (C) Female Marilyn:Rag2−/− mice were injected i.v with PBS or H-Y Dby peptide. 5 days later, 3D reconstructions of thymic lobes were then generated from serial sections stained with antibodies against K14 and DAPI. 3D reconstructions depicting the thymic lobes (light blue, DAPI) and medulla (red, K14) are shown: axes are in mm. Volumes and percentages of the thymic medulla are indicated. (D) The graph depicts the volumes (mm3) of individual medullary islets in thymic lobes from Marilyn:Rag2
−/− mice injected with PBS or Dby H-Y peptide. Horizontal lines represent medians and SEM. Numbers of isolated medullary islets in the thymic lobes are indicated below. The 3D reconstructions can be visualized in movies S3, S4.
(TIFF)Click here for additional data file.
3D reconstruction of an entire thymic lobe from
mouse injected with PBS. Thymic and medullary volumes were reconstructed using a whole thymic lobe. 20 µm thick serial sections were stained with DAPI (light blue) and antibodies against K14 (red). Volume rendering was performed from epifluorescence images, as described in methods. All axes are graduated in mm.
(AVI)Click here for additional data file.
3D reconstruction of an entire thymic lobe from
mouse injected with the OVA Volumes were determined as described for Movie S1.
(AVI)Click here for additional data file.
3D reconstruction of an entire thymic lobe from female
:
Volumes were determined as described for Movie S1.
(AVI)Click here for additional data file.(AVI)Click here for additional data file.
Authors: Anna I Proietto; Serani van Dommelen; Penghui Zhou; Alexandra Rizzitelli; Angela D'Amico; Raymond J Steptoe; Shalin H Naik; Mireille H Lahoud; Yang Liu; Pan Zheng; Ken Shortman; Li Wu Journal: Proc Natl Acad Sci U S A Date: 2008-12-10 Impact factor: 11.205
Authors: Mathias Heikenwalder; Marco Prinz; Nicolas Zeller; Karl S Lang; Tobias Junt; Simona Rossi; Alexei Tumanov; Hauke Schmidt; Josef Priller; Lukas Flatz; Thomas Rülicke; Andrew J Macpherson; Georg A Holländer; Sergei A Nedospasov; Adriano Aguzzi Journal: Am J Pathol Date: 2008-05-15 Impact factor: 4.307
Authors: Marie Le Borgne; Ena Ladi; Ivan Dzhagalov; Paul Herzmark; Ying Fang Liao; Arup K Chakraborty; Ellen A Robey Journal: Nat Immunol Date: 2009-06-21 Impact factor: 25.606
Authors: Simona W Rossi; Mi-Yeon Kim; Andreas Leibbrandt; Sonia M Parnell; William E Jenkinson; Stephanie H Glanville; Fiona M McConnell; Hamish S Scott; Josef M Penninger; Eric J Jenkinson; Peter J L Lane; Graham Anderson Journal: J Exp Med Date: 2007-05-14 Impact factor: 14.307
Authors: Joy A Williams; Jingjing Zhang; Hyein Jeon; Takeshi Nitta; Izumi Ohigashi; David Klug; Michael J Kruhlak; Baishakhi Choudhury; Susan O Sharrow; Larry Granger; Anthony Adams; Michael A Eckhaus; S Rhiannon Jenkinson; Ellen R Richie; Ronald E Gress; Yousuke Takahama; Richard J Hodes Journal: J Immunol Date: 2013-12-13 Impact factor: 5.422
Authors: S Rhiannon Jenkinson; Joy A Williams; Hyein Jeon; Jingjing Zhang; Takeshi Nitta; Izumi Ohigashi; Michael Kruhlak; Saulius Zuklys; Susan Sharrow; Anthony Adams; Larry Granger; Yongwon Choi; Ulrich Siebenlist; Gail A Bishop; Georg A Hollander; Yousuke Takahama; Richard J Hodes Journal: Proc Natl Acad Sci U S A Date: 2013-12-09 Impact factor: 11.205
Authors: Beth Lucas; Nicholas I McCarthy; Song Baik; Emilie Cosway; Kieran D James; Sonia M Parnell; Andrea J White; William E Jenkinson; Graham Anderson Journal: Immunol Rev Date: 2016-05 Impact factor: 12.988